Filing Flows › Cannapharmarx (CPMD) › Q1 2026 › vs Q1 2025
Cannapharmarx (CPMD) Q1 2026 vs Q1 2025 (year over year)
Cannapharmarx's revenue rose $292K (+87%) from $335K in Q1 2025 to $627K in Q1 2026.
Cannapharmarx, Q1 2026: revenue $627K (+87% year over year), operating margin -108.7%, net loss $382K, operating cash flow −$244K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $627K | $335K | $292K | +87% |
| Other income, net | $300K | −$13K | $313K | — |
| Net loss | $382K | $691K | −$309K | -45% |
| Costs & expenses | $1.3M | $1.0M | $284K | +28% |
| Operating costs | $1.3M | $1.0M | $297K | +29% |
| Cost of revenue | $1.0M | $838K | $199K | +24% |
| General & admin | $36K | $39K | −$3K | -7% |
| Other operating costs | $237K | $136K | $101K | +74% |
| Operating cash sources | $382K | $691K | −$309K | -45% |
| Depreciation & amortization | $16K | $0 | $16K | — |
| Working capital & other | $123K | $89K | $33K | +37% |
| Cash used in operations | $244K | $601K | −$358K | -59% |
| Net loss absorbed | $382K | $691K | −$309K | -45% |
Questions
How much did Cannapharmarx's revenue grow year over year in Q1 2026?
Cannapharmarx's revenue rose $292K (+87%) from $335K in Q1 2025 to $627K in Q1 2026.